The biology of hormone refractory prostate cancer. Why does it develop?
about
LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancerProhibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genesClinical and experimental progression of a new model of human prostate cancer and therapeutic approachTranscriptional programs activated by exposure of human prostate cancer cells to androgenDichotomy in the Epigenetic Mark Lysine Acetylation is Critical for the Proliferation of Prostate Cancer Cellsαvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer through JNK1-Mediated Activation of Androgen Receptor.Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistanceIdentification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens.Curcumin Inhibits Prostate Cancer Bone Metastasis by Up-Regulating Bone Morphogenic Protein-7 in VivoAndrogen receptor as a driver of therapeutic resistance in advanced prostate cancer.TPL2/COT/MAP3K8 (TPL2) activation promotes androgen depletion-independent (ADI) prostate cancer growth.Chemotherapy for patients with advanced prostate carcinoma: a new option for therapy.Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault.Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiationEpigenetics of prostate cancer: beyond DNA methylationEmerging targets in the AKT pathway for treatment of androgen-independent prostatic adenocarcinoma.Identification of secreted glycoproteins of human prostate and bladder stromal cells by comparative quantitative proteomics.Controversies surrounding androgen deprivation for prostate cancer.Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling.Serum prosaposin levels are increased in patients with advanced prostate cancer.Castration-resistant prostate cancer: potential targets and therapies.The androgen receptor and mechanisms for androgen independence in prostate cancer.Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5Multi-Parametric MRI-Directed Focal Salvage Permanent Interstitial Brachytherapy for Locally Recurrent Adenocarcinoma of the Prostate: A Novel Approach.The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaPExperimental evidence of persistent androgen-receptor-dependency in castration-resistant prostate cancer.Prostate cancer and metastasis initiating stem cells.Targeted therapy of cancer: new roles for pathologists--prostate cancer.Oxidative stress in prostate cancer.ARP2, a novel pro-apoptotic protein expressed in epithelial prostate cancer LNCaP cells and epithelial ovary CHO transformed cells.Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancerMolecular targets for radiation oncology in prostate cancer.Adaptation and clonal selection models of castration-resistant prostate cancer: current perspective.The nrf1 and nrf2 balance in oxidative stress regulation and androgen signaling in prostate cancer cells.Drug design strategies for the treatment of prostate cancer.Cytoskeleton targeting value in prostate cancer treatment.RalA regulates vascular endothelial growth factor-C (VEGF-C) synthesis in prostate cancer cells during androgen ablation.Androgen receptor-related diseases: what do we know?Establishment of prostate cancer spheres from a prostate cancer cell line after phenethyl isothiocyanate treatment and discovery of androgen-dependent reversible differentiation between sphere and neuroendocrine cells
P2860
Q21202034-8DB40F47-F1FD-4DD9-B59E-DB6160150233Q24314424-C3E9F804-D5B9-4D43-B3E8-CEAB4AE314CBQ24685731-8C438066-66A9-48D8-93C0-B746C4303DE4Q24802648-6F042A8A-4EC7-4BCE-A8BA-F6429F16A2D3Q26795738-703DFAEB-FC1C-4CE9-BCCD-ED5637A48199Q30276295-B840357B-E767-408E-94D2-707297E9B4FFQ30500080-1F6EF764-4BB7-4254-946D-AF7C36D55C0CQ33562480-96187855-4906-4C88-8561-B92125F0D895Q33767832-0997941E-FEB6-4F1A-8FDB-0A5EB11534EDQ33775723-9F955A34-B57F-44BB-8DD5-1683241E55F0Q33803841-5222141B-0459-468F-B3E4-377144BA0808Q33970538-0290668C-3016-4FF6-8394-DB485625D8B1Q33995787-08B1F637-7A7F-4C96-883E-FC24546C3F7CQ34013858-55770036-6003-4060-964A-EF149C7C5D63Q34298595-B1AF9DF0-4C84-4975-9E95-555550815A7CQ34505232-6AB8EAEB-565C-44C8-88E9-8AF6F0D3DDCBQ34568941-513646C6-1EA6-4AB8-B70B-73FD1A7AB987Q34802793-CD532641-B449-4A73-9299-FC30845563D6Q34849222-A425B262-633E-42F3-9E9F-608967486DB1Q35157667-DC3BCDAD-DF79-4099-8771-155E42E76283Q36122311-BA2819EE-71AD-4ABF-8326-260813F5EC2AQ36196682-50D61FAC-3649-4315-8BD8-31AD89218C7DQ36276350-6C9FEEC4-2CF6-4DC2-8A75-F0505848B9FCQ36300065-0E1484A7-DADE-4FDE-8244-DEB448CFC7B6Q36609888-24A88118-29D1-4BC2-97B4-2A695025268FQ37084449-AFF48A95-D114-4F8E-890E-6210948C492DQ37139070-ADE6D41E-031E-4812-966A-94731C1A106AQ37139272-20D63C2B-54DD-4C2B-A63F-9C092AD94AEDQ37147772-560E3ABB-B304-435D-97EE-0D5C6FBA490CQ37382855-BC154ABB-B36D-447D-A6F1-E33039D31244Q37505601-A9CD22FA-D06A-4A55-92CC-1E43967848CDQ37683681-4D55A439-DB9C-46DD-9876-71C62CCE6667Q38014447-AE9358B1-8658-444F-9695-E8EDB6BDC795Q38060845-D2FE3A3E-9E92-4483-A3D8-45E998409BE7Q38166575-DA86214D-F45F-4B9A-ACA5-94C6CF2D63C7Q38264673-73FB76AD-C8F4-4FB3-A5FF-713DAB344386Q38265569-45E8F947-B327-4B6E-B4D0-8009FF773D74Q38309812-0EB81F15-4255-4C4C-B2F7-0927993EC612Q38780007-9BD5C81F-D4DA-4455-980A-4FB13E0934D7Q38781961-9EC26F92-EC93-478E-A89B-7339AFDBFBD8
P2860
The biology of hormone refractory prostate cancer. Why does it develop?
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The biology of hormone refractory prostate cancer. Why does it develop?
@ast
The biology of hormone refractory prostate cancer. Why does it develop?
@en
type
label
The biology of hormone refractory prostate cancer. Why does it develop?
@ast
The biology of hormone refractory prostate cancer. Why does it develop?
@en
prefLabel
The biology of hormone refractory prostate cancer. Why does it develop?
@ast
The biology of hormone refractory prostate cancer. Why does it develop?
@en
P1476
The biology of hormone refractory prostate cancer. Why does it develop?
@en
P2093
P304
P356
10.1016/S0094-0143(05)70066-5
P577
1999-05-01T00:00:00Z